OQS
LENZ

Occudo Quantitative Strategies’s LENZ Therapeutics LENZ Stock Holding History

Occudo Quantitative Strategies’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$831K Buy
+146,376
New +$1.18M 0.04% 408
2023
Q1 		– Sell
-2,119
Closed -$49.2K – 1243
2022
Q4 		$49.2K Sell
2,119
-1,235
-37% -$28.6K 0.01% 884
2022
Q3 		$74K Sell
3,354
-3,966
-54% -$94.5K 0.01% 1064
2022
Q2 		$141K Buy
+7,320
New +$163K 0.01% 969

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Occudo Quantitative Strategies's LENZ Position: Q2 2026 in Review

Occudo Quantitative Strategies opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 146,376 shares worth $831K. The stake represents 0.04% of the portfolio and ranks #408 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in LENZ as recently as Q4 2022.

Occudo Quantitative Strategies first reported a position in LENZ in Q2 2022 and has held it in 4 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Occudo Quantitative Strategies held 146,376 shares of LENZ Therapeutics worth $831K as of Q2 2026.
  • LENZ Therapeutics was a new Occudo Quantitative Strategies position in Q2 2026.
  • LENZ Therapeutics made up 0.04% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #408 holding.
  • Occudo Quantitative Strategies first reported a position in LENZ Therapeutics in Q2 2022 and has held it in 4 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.